SanBio Company Limited

TSE:4592.T

962 (JPY) • At close September 13, 2024
Bedrijfsnaam SanBio Company Limited
Symbool 4592.T
Munteenheid JPY
Prijs 962
Beurswaarde 66,022,475,584
Dividendpercentage 0%
52-weken bereik 380 - 1,489
Industrie Biotechnology
Sector Healthcare
CEO Mr. Keita Mori MBA
Website https://www.sanbio.jp

An error occurred while fetching data.

Over SanBio Company Limited

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes,

Vergelijkbare Aandelen

GNI Group Ltd. logo

GNI Group Ltd.

2160.T

2,495 JPY

AnGes, Inc. logo

AnGes, Inc.

4563.T

49 JPY

CellSource Co., Ltd. logo

CellSource Co., Ltd.

4880.T

1,354 JPY

Eiken Chemical Co., Ltd. logo

Eiken Chemical Co., Ltd.

4549.T

2,305 JPY

Pharma Foods International Co., Ltd. logo

Pharma Foods International Co., Ltd.

2929.T

888 JPY

Elan Corporation logo

Elan Corporation

6099.T

813 JPY

Genky DrugStores Co., Ltd. logo

Genky DrugStores Co., Ltd.

9267.T

3,675 JPY

CYBERDYNE Inc. logo

CYBERDYNE Inc.

7779.T

204 JPY

Solasto Corporation logo

Solasto Corporation

6197.T

539 JPY

MedPeer,Inc. logo

MedPeer,Inc.

6095.T

590 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)